A comparative review of generic quality-of-life instruments

PharmacoEconomics

Volumn 17, Issue 1, 2000, Pages 13-35

  Coons, Stephen Joel ^a   Rao, Sumati ^a   Keininger, Dorothy L ^b   Hays, Ron D ^c,d  

^a UNIVERSITY OF ARIZONA   (United States)

^b Mapi Research Institute   (France)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d RAND CORPORATION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CONTROLLED STUDY; CULTURAL FACTOR; EVALUATION; HEALTH CARE; HEALTH STATUS; HEALTH SURVEY; LANGUAGE; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; QUALITY OF LIFE; RATING SCALE; RELIABILITY; REVIEW; TREATMENT OUTCOME; WELLBEING;

EID: 0033957001     PISSN: 11707690     EISSN: None     Source Type: Journal    
DOI: 10.2165/00019053-200017010-00002     Document Type: Review

References (146)

1. 1. Guyatt GH, Feeny DH, Patrick DL. Measuring health-related quality of life. Ann Intern Med 1993; 118: 622-9
2. 2. Patrick DL, Deyo RA. Generic and disease-specific measures in assessing health status and quality of life. Med Care 1989; 27: S217-32
3. 3. Bowling A. Measuring health: a review of quality of life measurement scales. 2nd ed. Buckingham: Open University Press, 1997
4. 4. McDowell I, Newell C. Measuring health: a guide to rating scales and questionnaires. 2nd ed. New York: Oxford University Press, 1996
5. 5. Lohr KN, Aaronson NK, Alonso J, et al. Evaluating quality of life and health status instruments: development of scientific review criteria. Clin Ther 1996; 18: 979-92
6. 6. Hays RD, Hadorn D. Responsiveness to change: an aspect of validity, not a separate dimension. Qual Life Res 1992; 1: 73-5
7. 7. Nunnally JC, Bernstein IH. Psychometric theory. 3rd ed. New York (NY): McGraw-Hill, 1994
8. 8. Helmstadter GC. Principles of psychological measurement. New York (NY): Appleton Century Crofts, 1964
9. 9. Weiner EA, Stewart BJ. Assessing individuals. Boston (MA): Little Brown, 1984
10. 10. Fleiss JL. Statistical methods for rates and proportions. 2nd ed. New York (NY): Wiley, 1981
11. 11. Landis JR, Koch GG. The measurement of observer agreement for categorical data. Biometrics 1977; 33: 159-74
12. 12. Stewart AL, Sherbourne CD, Hays RD, et al. Summary and discussion of MOS measures. In: Stewart AL, Ware JE, editors. Measuring functioning and well-being: the Medical Outcomes Study approach. Durham (NC): Duke University Press, 1992: 345-71
13. 13. Hays RD, Prince-Embury S, Chen H. RAND-36 Health Status Inventory: manual. San Antonio (TX): The Psychological Corporation, 1998
14. 14. Ware JE, Sherbourne CD, Davies AR. Developing and testing the MOS 20-Item Short-Form Health Survey: a general population application. In: Stewart AL, Ware JE, editors. Measuring functioning and well-being: the Medical Outcomes Study approach. Durham (NC): Duke University Press, 1992: 277-90
15. 15. Stewart AL, Hays RD, Ware JE. The MOS Short-Form General Health Survey: reliability and validity in a patient population. Med Care 1998; 26: 724-35
16. 16. Hays RD, Sherbourne CD, Mazel RM. User's manual for the Medical Outcomes Study (MOS) core measures of health-related quality of life. Santa Monica (CA): RAND, 1995: MR-162-RC
17. 17. Stewart AL, Ware JE, editors. Measuring functioning and well-being: the Medical Outcomes Study approach. Durham (NC): Duke University Press, 1992
18. 18. Ware JE, Sherbourne CD. The MOS 36-Item Short-Form Health Survey (SF-36): I. Conceptual framework and item selection. Med Care 1992; 30: 473-81
19. 19. Hays RD, Sherbourne CD, Mazel RM. The RAND 36-Item Health Survey 1.0. Health Econ 1993; 2: 217-27
20. 20. Essink-Bot ML, Krabbe PFM, Bonsel GJ, et al. An empirical comparison of four generic health status measures. Med Care 1997; 35: 522-37
21. 21. Hays RD, Marshall GN, Wang EYI, et al. Four-year cross-lagged associations between physical and mental health in the Medical Outcomes Study. J Consult Clin Psychol 1994; 62: 441-9
22. 22. Ware JE, Kosinski M, Bayliss MS, et al. Comparisons of methods for the scoring and statistical analysis of SF-36 health profile and summary measures: summary of results from the Medical Outcomes Study. Med Care 1995; 33: AS264-79
23. 23. Dexter PR, Stump TE, Tierney WM, et al. The psychometric properties of the SF-36 health survey among older adults in a clinical setting. J Clin Geropsychology 1996; 2: 225-37
24. 24. Shadbolt B, McCallum J, Singh M. Health outcomes by self-report: validity of the SF-36 among Australian hospital patients. Qual Life Res 1997; 6: 343-52
25. 25. Rummel RJ. Applied factor analysis. Evanston (IL); Northwestern University Press, 1970
26. 26. Ware JE, Kosinski M. SF-36 Health Survey (version 2.0) [technical note]. Boston (MA): The Health Institute, 1996
27. 27. McHorney CA, Ware JE, Lu RJF, et al. The MOS 36-Item Short-Form Health Survey (SF-36): III. Tests of data quality, scaling assumptions, and reliability across diverse patient groups. Med Care 1994; 32: 40-66
28. 28. Andresen EM, Bowley N, Rothenberg BM, et al. Test-retest performance of a mailed version of the Medical Outcomes Study 36-ltem Short-Form Health Survey among older adults. Med Care 1996; 34: 1165-70
29. 29. Hays RD, Kallich JD, Mapes DL, et al. Development of the Kidney Disease Quality of Life (KDQOL) instrument. Qual Life Res 1994; 3: 329-38
30. 30. Kurlin PS, Davies AR, Meyer KB, et al. Patient-based health status measures in outpatient dialysis: early experience in developing an outcomes assessment program. Med Care 1992; 30: MS136-49
31. 31. Kantz ME, Harris WJ, Levitsky K, et al. Methods for assessing condition-specific and generic functional status outcomes after total knee replacement. Med Care 1992; 30: MS240-52
32. 32. Wagner AK, Keller SD, Kosinski M, et al. Advances in methods for assessing the impact of epilepsy and antiepilepsy drug therapy on patients health-related quality of life. Qual Life Res 1995; 4: 115-34
33. 33. Brazier JK, Harper R, Jones NMB, et al. Validating the SF-36 health survey questionnaire: new outcome measure for primary-care. BMJ 1992; 305: 160-4
34. 34. Hays RD, Hayashi T. Beyond internal consistency: rationale and user's guide for Multitrait Analysis Program on the microcomputer. Behav Res Methods, Instruments, and Computers 1990; 22: 167-75
35. 35. McHorney CA, Jr Ware JE, Raczek AE. The MOS 36-Item Short-Form Health Survey (SF-36): II. Psychometric and clinical tests of validity in measuring physical and mental health constructs. Med Care 1993; 31: 247-63
36. 36. McHorney CA, Jr Ware JE, Rogers W, et al. The validity and relative precision of MOS short-and long-form health status scale and Dartmouth COOP charts. Med Care 1992; 30 (5 Suppl.): MS253-65
37. 37. Vickrey BG, Hays RD, Rausch R, et al. Quality of life of epilepsy surgery patients as compared with outpatients with hypertension, diabetes, heart disease, and/or depressive symptoms. Epilepsia 1994; 35: 597-607
38. 38. Ganz, PA, Day R, Ware JE, et al. Base-line quality of life assessment in the national surgical adjuvant breast and bowel project breast cancer prevention trial. J Natl Cancer Inst 1995; 87: 1372-82
39. 39. Sherbourne CD, Wells KB, Judd LL. Functioning and well-being of patients with panic disorder. Am J Psychiatry 1996; 153: 213-8
40. 40. Lansky D, Butler JBV, Waller FT. Using health status measures in the hospital setting: from acute care to 'outcome management'. Med Care 1992; 30: MS57-73
41. 41. Solomon GD. Evolution of the measurement of quality of life in migraine. Neurol 1997; 48: S10-5
42. 42. Garratt AM, Ruta DA, Abdalla MI, et al. Responsiveness of the SF-36 and a condition-specific measure of health for patients with varicose veins. Qual Life Res 1996; 5: 223-34
43. 43. Ware JE. The SF-36 health survey. In: Spilker B, editor. Quality of life and pharmacoeconomics in clinical trials. 2nd ed. Philadelphia (PA): Lippincott-Raven, 1996: 337-45
44. 44. McHorney CA, Kosinski M, Ware JE. Comparisons of the costs and quality of norms for the SF-36 health survey collected by mail versus telephone interview: results from a national survey. Med Care 1994; 32: 551-67
45. 45. Keller SD, Bayliss MS, Ware JE, et al. Comparison of responses to SF-36 health survey questions with one-week and four-week recall periods. Health Serv Res 1997; 32: 367-84
46. 46. Medical Outcomes Trust. Medical Outcomes Trust: approved instruments. Med Outcomes Trust Bull 1998; 6 (3): 15
47. 47. Aaronson NK, Acquadro C, Alonso J, et al. International quality of life assessment (IQOLA) project. Qual Life Res 1992; 1: 349-51
48. 48. Anderson RT, Aaronson NK, Bullinger M, et al. A review of the progress towards developing health-related quality of life instruments for international clinical studies and outcomes research. Pharmacoeconomics 1996; 10: 336-55
49. 49. Ware JE, Gandek B. Overview of the SF-36 health survey and the international quality of life assessment (IQOLA) project. J Clin Epidemiol 1998; 51: 903-12
50. 50. McEwen J, McKenna SP. Nottingham Health Profile. In: Spilker B, editor. Quality of life and pharmacoeconomics in clinical trials. 2nd ed. Philadelphia (PA): Lippincott-Raven, 1996: 281-6
51. 51. Hunt SM, McEwen J, McKenna SP. Measuring health status. London: Croom Helm, 1986
52. 52. McKenna SP, Hunt SM, McEwen J. Weighting the seriousness of perceived health problems using Thurstone's method of paired comparisons. Int J Epidemiol 1981; 10: 93-7
53. 53. Hunt SM, McKenna SP, McEwen J, et al. The Nottingham Health Profile: subjective health status and medical consultations. Soc Sci Med 1981; 15: 221-9
54. 54. Jenkinson C, Fitzpatrick R, Argyle M. The Nottingham Health Profile: an analysis of its sensitivity in differentiating illness groups. Soc Sci Med 1988; 27: 1411-14
55. 55. O'Brien B. Assessment of treatment in heart disease. In: Teeling Smith G, editor. Measuring health: a practical approach. Chichester: John Wiley and Sons, 1988: 191-210
56. 56. Hunt SM, McEwen H, McKenna SP. Measuring health status: a new tool for clinicians and epidemiologists. J R Coll General Pract 1985; 35: 185-8
57. 57. Hunt SM, McEwen J, McKenna SP, et al. Subjective health assessments and the perceived outcome of minor surgery. J Psychosom Res 1984; 28: 105-14
58. 58. Hunt SM, Alonso J, Bucquet D, et al. Cross-cultural adaptation of health measures. Health Policy 1991; 19: 33-44
59. 59. Bergner M, Bobbitt RA, Carter WB, et al. The Sickness Impact Profile: development and final revision of a health status measure. Med Care 1981; 19: 787-805
60. 60. Bergner M. Development, testing and use of the Sickness Impact Profile. In: Walker SR, Rosser RM, editors. Quality of life assessment: key issues in the 1990s. Boston (MA): Kluwer Academic Publishers, 1993: 95-109
61. 61. Bergner M, Bobbitt RA, Kressel S, et al. The Sickness Impact Profile: conceptual formulation and methodology for the development of a health status measure. Int J Health Services 1976; 6: 393-415
62. 62. Damiano AM. The Sickness Impact Profile. In: Spilker B, editor. Quality of life and pharmacoeconomics in clinical trials. 2nd ed. Philadelphia (PA): Lippincott-Raven, 1996: 347-54
63. 63. Carter WB, Bobbitt RA, Bergner M, et al. Validation of an interval scaling: the Sickness Impact Profile. Health Serv Res 1976; 11: 516-28
64. 64. Pollard WB, Bobbitt RA, Bergner M, et al. The Sickness Impact Profile: reliability of a health status measure. Med Care 1976; 14: 146-55
65. 65. Bergner M, Bobbitt RA, Pollard WE, et al. The Sickness Impact Profile: validation of a health status measure. Med Care 1976; 14: 57-67
66. 66. Deyo RA, Inui TS, Leininger JD, et al. Measuring functional outcomes in chronic disease: a comparison of traditional scales and a self-administered health status questionnaire in patients with rheumatoid arthritis. Med Care 1983; 21: 180-92
67. 67. DeBruin AF, De Witte LP, Stevens F, et al. Sickness Impact Profile: the state of the art of a generic functional status measure. Soc Sci Med 1992; 35: 1003-14
68. 68. Read LJ, Quinn RJ, Hoefer MA. Measuring overall health: an evaluation of three important approaches. J Chron Dis 1987; 40: 7S-21S
69. 69. Hall J, Hall N, Fisher B, et al. Measurement of outcomes of general practice: comparison of three health status measures. Fam Pract 1987; 4: 117-22
70. 70. Vetter N, Smith A, Sastry D, et al. Day Hospital: pilot study report. Research team for the care of elderly people. Cardiff: Department of Geriatrics, St David's Hospital, 1989
71. 71. Sullivan M, Ahlmen M, Bjella A, et al. Health status assessment in rheumatoid arthritis: II. Evaluation of a modified Shorter Sickness Impact Profile. J Rheumatol 1993; 20: 1500-7
72. 72. Gerety MB, Cornell JE, Mulrow CD, et al. The Sickness Impact Profile for nursing homes (SIP-NH). J Gerontol 1994; 49: M2-8
73. 73. Roland M, Morris R. A study of the natural history of back pain. Part I: development of a reliable and sensitive measure of disability in low-back pain. Spine 1983; 8: 141-4
74. 74. Patrick DL, Sittampalam Y, Somerville SM, et al. A cross cultural comparison of health status values. Am J Public Health 1985; 75: 1402-7
75. 75. Chwalow AJ, Lurie A, Bean K, et al. A French version of the Sickness Impact Profile (SIP): stages in the cross cultural validation of a generic quality of life scale. Fundam Clin Pharmacol 1992; 6: 319-26
76. 76. Esteva M, Gonzalez N, Ruiz M. Reliability and validity of a Spanish version of the Sickness Impact Profile [abstract]. Arthritis Rheum 1992; 35 Suppl. 9: S219
77. 77. Sullivan M, Ahlmen M, Archenholtz B, et al. Measuring health in rheumatic disorders by means of a Swedish version of the Sickness Impact Profile: results from a population study. Scand J Rheumatol 1986; 15: 193-200
78. 78. Jacobs HM, Luttik A, Touw-Otten FWMM, et al. Measuring impact of sickness in patients with nonspecific abdominal complaints in a Dutch family practice setting. Med Care 1992; 30: 244-51
79. 79. Nelson EC, Wasson JH, Johnson DJ, et al. Dartmouth COOP functional health assessment charts: brief measures for clinical practice. In: Spilker B, editor. Quality of life and pharmacoeconomics in clinical trials. 2nd ed. Philadelphia (PA): Lippincott-Raven, 1996: 161-8
80. 80. Nelson E, Wasson J, Kirk J, et al. Assessment of function in routine clinical practice: description of the COOP chart method and preliminary findings. J Chron Dis 1987; 40 Suppl. 1: 55S-63S
81. 81. Landgraf JM, Nelson EC, Hays RD, et al. Assessing function: does it really make a difference? A preliminary evaluation of acceptability and utility of the COOP function charts. In: Lipkin M, editor. Functional status measurement in primary care: frontiers of primary care. New York (NY): Springer-Verlag, 1990: 150-65
82. 82. Froom J. Functional status measurement in primary care. World Organization of National Colleges, Academics, and Academic Association of General Practitioners/Family Physicians (WONCA) Committee on International Classification Statement on Functional Status Assessment; 1988 Oct 24-28: Calgary. New York (NY): Springer-Verlag, 1990: xiii-xvii
83. 83. Westbury RC. Use of the Dartmouth COOP Charts in a Calgary practice. In: Lipkin M, editor. Functional status measurement in primary care. New York (NY): Springer-Verlag, 1990: 166-80
84. 84. Larson CO, Hays RD, Nelson EC. Do the pictures influence scores on the Dartmouth COOP charts? Qual Life Res 1992; 1: 247-9
85. 85. Nelson EC, Landgraf JM, Hays RD, et al. The functional status of patients: how can it be measured in physicians office? Med Care 1990; 28: 1111-26
86. 86. Nelson EC, Landgraf JM, Hays RD, et al. The COOP function charts: a system to measure patient function in physician's offices. In: Lipkin M, editor. Functional status measurement in primary care: frontiers of primary care. New York (NY): Springer-Verlag, 1990: 97-131
87. 87. Meyboom-de Jong B, Smith RJA. Studies with the Dartmouth COOP charts in general practice: comparison with the Not-tingham Health Profile and the General Health Questionnaire. In: Lipkin M, editor. Functional status measurement in primary care: frontiers of primary care. New York (NY): Springer-Verlag, 1990: 132-49
88. 88. Wasson JH, Stukel TA, Weiss JE, et al. A randomized trial of use of patient self-assessment data to improve community practices. Eff Clin Pract 1999; 2: 1-10
89. 89. Wasson JH, Kairys SW, Nelson EC, et al. A short survey for assessing health and social problems of adolescents. J Fam Pract 1994; 38: 489-94
90. 90. Shigemoto H. A trial of the Dartmouth COOP Charts in Japan. In: Lipkin M, editor. Functional status measurement in primary care. New York (NY): Springer-Verlag, 1990: 181-7
91. 91. Drummond MF, O'Brien B, Stoddart GL, et al. Methods for the evaluation of health care programmes. 2nd ed. Oxford: Oxford University Press, 1997
92. 92. Feeny DH, Torrance GW, Furlong WJ. Health Utilities Index. In: Spilker B, editor. Quality of life and pharmacoeconomics in clinical trials. 2nd ed. Philadelphia (PA): Lippincott-Raven Publishers, 1996: 239-52
93. 93. Coons SJ, Kaplan RM. Cost-utility analysis. In: Bootman JL, Townsend RJ, McGhan WF, editors. Principles of pharmacoeconomics. 2nd ed. Cincinnati (OH): Harvey Whitney Books Company, 1996: 102-26
94. 94. Torrance GW, Feeny D. Utilities in quality-adjusted life years. Int J Technol Assess Health Care 1989; 5: 559-75
95. 95. Gold MR, Siegel JE, Russell LB, et al. Cost-effectiveness in health and medicine. New York (NY): Oxford University Press, 1996
96. 96. Kaplan RM, Anderson JP. The General Health Policy Model: an integrated approach. In: Spilker B, editor. Quality of life and pharmacoeconomics in clinical trials. 2nd ed. Philadelphia (PA): Lippincott-Raven Publishers, 1996: 309-22
97. 97. Fanshel S, Bush JW. A Health Status Index and its application to health services outcomes. Oper Res 1970; 18: 1021-66
98. 98. Bush JW, Chen MM, Patrick DL. Health Status Index in cost effectiveness: analysis of PKU program. In: Berg RL, editor. Health Status Index. Chicago (IL): Hospital Research and Educational Trust, 1973: 172-208
99. 99. Kaplan RM, Sieber WJ, Ganiats TG. The Quality of Well-Being Scale: comparison of the interview-administered version with a self-administered questionnaire. Psychol Health 1997; 12: 783-91
100. 100. Kaplan RM, Bush JW, Berry CC. Health status: types of validity and the Index of Well-Being. Health Serv Res 1976; 11: 478-507
101. 101. Kaplan RM, Bush JW, Berry CC. Reliability, stability, and generalizability of a Health Status Index: proceedings of the social status section. Washington, DC: American Statistical Association, 1978: 704-9
102. 102. Anderson JP, Kaplan RM, Berry CC, et al. Interday reliability of function assessment for a health status measure: the Quality of Well-Being Scale. Med Care 1989; 27: 1076-84
103. 103. Siu AL, Hays RD, Ouslander JG, et al. Measuring functioning and health in the very old. J Gerontol 1993; 48: M10-4
104. 104. Kaplan RM, Atkins CJ, Timms R. Validity of a Quality of Well-Being Scale as an outcome measure in chronic obstructive pulmonary disease. J Chron Dis 1984; 37: 85-9
105. 105. Orenstein DM, Nixon PA, Ross EA, et al. The Quality of well-being in cystic fibrosis. Chest 1989; 95: 344-7
106. 106. Kerner DN, Patterson TL, Grant I, et al. Validity of the Quality of Well-Being Scale for patients with Alzheimer's disease. J Aging Health 1998; 10: 44-61
107. 107. Andresen EM, Patrick DL, Carter WB, et al. Comparing the performance of health status measures for healthy older adults. J Am Geriatr Soc 1995; 43: 1030-4
108. 108. Patterson TL, Kaplan RM, Grant I, et al. Quality of well-being in late-life psychosis. Psychiatry Res 1996; 63: 169-81
109. 109. Pyne JM, Patterson TL, Kaplan RM, et al. Assessment of the quality of life of patients with major depression. Psychiatr Serv 1997; 48: 224-30
110. 110. Kaplan RM, Anderson JP, Patterson TL, et al. Validity of the Quality of Well-Being Scale for persons with human immunodeficiency virus infection. Psychosom Med 1995; 57: 138-57
111. 111. Bombardier C, Ware J, Russell IJ, et al. Auranofin therapy and quality of life in patients with rheumatoid arthritis: results of a multicenter trial. Am J Med 1986; 81: 565-78
112. 112. Wu AW, Mathews WC, Brysk LT, et al. Quality of life in a placebo-controlled trial of zidovudine in patients with AIDS and AIDS-related complex. J AIDS 1990; 3: 683-90
113. 113. Balaban DJ, Sagi PC, Goldfarb NI, et al. Weights for scoring the Quality of Well-Being instrument among rheumatoid arthritics. Med Care 1986; 24: 973-80
114. 114. Hughes TE, Coons SJ, Kaplan RM, et al. Reweighting the Quality of Well-Being Scale in HIV-infected subjects [abstract]. Qual Life Res 1994; 3: 79-80
115. 115. Hays RD, Siu AL, Keeler E, et al. Long-term care residents' preferences for health states on the Quality of Well-Being Scale. Med Decis Making 1996; 16: 254-61
116. 116. Andresen EM, Rothenberg BM, Kaplan RM. Performance of a self-administered mailed version of the Quality of Well Being (QWB-SA) questionnaire among older adults. Med Care 1998; 36: 1349-60
117. 117. Torrance GW, Boyle MH, Horwood SP. Application of multi-attribute utility theory to measure social preferences for health states. Oper Res 1982; 30: 1043-69
118. 118. Torrance GW, Zhang Y, Feeny D, et al. Multi-attribute preference functions for a comprehensive health status classification system. Hamilton (ON): McMaster University, Centre for Health Economics and Policy Analysis, 1992. Working paper no.: 92-18
119. 119. Feeny D, Torrance GW, Goldsmith C, et al. A multiattribute approach to population health status. Hamilton (ON): McMaster University, Centre for Health Economics and Policy Analysis, 1994. Working paper no.: 94-5
120. 120. Furlong W, Feeny D, Torrance GW, et al. Multiplicative multi-attribute utility function for the Health Utilities Index Mark 3 (HUI3) system: a technical report. Hamilton (ON): McMaster University Centre for Health Economics and Policy Analysis, 1998. Working paper no.: 98-11
121. 121. Boyle MH, Furlong W, Feeny D, et al. Reliability of the Health Utilities Index-Mark III used in the 1991 cycle 6 Canadian General Social Survey Health Questionnaire. Qual Life Res 1995; 4: 249-57
122. 122. Torrance GW, Furlong W, Feeny D, et al. Multi-attribute preference functions. Pharmacoeconomics 1995; 7: 503-20
123. 123. Saigal S, Rosenbaum P, Stoskopf B, et al. Comprehensive assessment of the health status of extremely low birth weight children at eight years of age: comparison with a reference group. J Pediatr 1994; 125: 411-7
124. 124. Saigal S, Feeny D, Furlong W, et al. Comparison of the health-related quality of life of extremely low birth weight children and a reference group of children at age eight years. J Pediatr 1994; 125: 418-25
125. 125. Barr RD, Petrie C, Furlong W, et al. Health-related quality of life during post-inducing chemotherapy in children with acute lymphoblastic leukemia in remission: an influence of cortico-steroid therapy. Int J Oncol 1997; 11: 333-9
126. 126. Feeny DH, Furlong W, Barr RD, et al. A comprehensive multi-attribute system for classifying the health status of survivors of childhood cancer. J Clin Oncol 1992; 10: 923-8
127. 127. Barr RD, Furlong W, Dawson S, et al. An assessment of global health status in survivors of acute lymphoblastic leukemia in childhood. Am J Pediatr Hematol Oncol 1993; 15: 284-90
128. 128. Feeny D, Leiper A, Barr RD, et al. The comprehensive assessment of health status in survivors of childhood cancer: application to high risk acute lymphoblastic leukaemia. Br J Cancer 1993; 67: 1047-52
129. 129. Barr RD, Pai MKR, Weitzman S, et al. A multi-attribute approach to health status measurement and clinical management-illustrated by an application to brain tumors in childhood. Int 3 Oncol 1994; 4: 639-48
130. 130. Feeny D, Furlong W, Torrance GW. The Health Utilities Index: an update. Qual Life Newslett 1999; May-Aug: 8-9
131. 131. The EuroQol Group. EuroQol: a new facility lor the measurement of health-related quality of life. Health Policy 1990; 16: 199-208
132. 132. Kind P. Measuring valuations for health states: a survey of patients in general practice. York: Centre for Health Economics, University of York, 1990. Discussion paper no.: 76
133. 133. Kind P. The EuroQol instrument: an index of health-related quality of life. In: Spilker B, editor. Quality of life and pharmacoeconomics in clinical trials. 2nd ed. Philadelphia (PA): Lippincott-Raven Publishers, 1996: 191-201
134. 134. Dolan P, Gudex C, Kind P, et al. A social tariff for EuroQol: results from a UK general population survey. York: Center for Health Economics, University of York, 1995. Discussion paper no.: 138
135. 135. Essink-Bot ML, Bonsel GJ, van der Maas PJ. Valuations of health states by the general public: feasibility of a standardized measurement procedure. Soc Sci Med 1990; 31: 1201-6
136. 136. Brooks RG, Jendteg S, Lindgren B, et al. EuroQoL: health related quality of life measurement. Results of the Swedish questionnaire exercise. Health Policy 1991; 18: 37-48
137. 137. Nord E. EuroQol: health-related quality of life measurement. Valuations of health states by the general public in Norway. Health Policy 1991; 18: 25-36
138. 138. Johnson JA, Coons SJ. Comparison of the EQ-5D and the SF-12 in an adult US sample. Qual Life Res 1998; 7: 155-66
139. 139. van Agt HME, Essink-Bot M-L, Krabbe PFM, et al. Test-retest reliability of health state valuations collected with the EuroQol questionnaire. Soc Sci Med 1994, 39: 1537-44
140. 140. Dorman P, Slattery J, Farrell B, et al. Qualitative comparison of the reliability of health status assessments with the EuroQol and SF-36 questionnaires after stroke. Stroke 1998; 29: 63-8
141. 141. Hurst NP, Kind P, Ruta D, et al. Measuring health-related quality of life in rheumatoid arthritis: validity, responsiveness and reliability of EuroQol (EQ-5D). Br J Rheumatol 1997; 36: 551-9
142. 142. Brazier J, Jones N, Kind P. Testing the validity of the EuroQol and comparing it with the SF-36 health survey questionnaire. Qual Life Res 1993; 2: 169-80
143. 143. Hurst NP, Jobanputra P, Hunter M, et al. Validity of EuroQol: a generic health status instrument in patients with rheumatoid arthritis. Br J Rheumatol 1994; 33: 655-62
144. 144. Brazier JE, Walters SJ, Nicholl JP, et al. Using the SF-36 and EuroQol on an elderly population. Qual Life Res 1996; 5: 195-204
145. 145. Coast J, Peters TJ, Richards SH, et al. Use of the EuroQoi among elderly acute care patients. Qual Life Res 1998; 7: 1-10
146. 146. de Charro F, Rabin R. EQ-5D from the EuroQol group: an update. Qual Life Newslett 1999; May-Aug: 3-4